思泉新材 reported revenue of ¥0.52B for the period ended 2026-06-30, +35.0% year on year. Net income was ¥0.04B, a 7.5% net margin on a 30.3% gross margin. Free cash flow for the period was ¥0.06B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.52B | +35.0% |
| Gross profit | ¥0.16B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.04B | +37.6% |
| Gross margin | 30.3% | Net margin 7.5% |
| Revenue Q/Q | +0.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.36B | 69.7% |
| R&D | ¥0.05B | 8.9% |
| SG&A | ¥0.05B | 9.7% |
| Tax & other | ¥0.00B | 0.4% |
| Item | Amount |
|---|---|
| Total assets | ¥1.71B |
| Total liabilities | ¥0.59B |
| Shareholders' equity | ¥1.12B |
| Equity / assets | 65.5% |
| Operating cash flow | ¥0.12B |
| Capital expenditure | ¥0.06B |
| Free cash flow | ¥0.06B |
| Cash conversion (OCF / net income) | 270% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
汉桑科技 ・ 乖宝宠物 ・ 维科精密 ・ 飞南资源 ・ 恒鑫生活 ・ 华阳智能 ・ 智迪科技 ・ 苏州规划 ・ 民生健康 ・ 中机认检 ・ 金凯生科 ・ 固高科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies